Skip to main content
Log in

Protein kinase C isozymes and substrates in mammary carcinogenesis

  • Published:
Journal of Mammary Gland Biology and Neoplasia Aims and scope Submit manuscript

Abstract

Protein kinase C (PKC) comprises a family of ubiquitously expressed phospholipid-dependent enzymes that regulate cell growth and differentiation. Several effectors that modify mammary cell biology work at least partially through PKC-dependent pathways. Studies with mammary epithelial cells and tissues have demonstrated probable roles for the PKCs in processes associated with carcinogenesis including proliferation, estrogen sensitivity, and apoptosis. The involvement of PKCs in this wide variety of responses may in part be explained by the expression of multiple PKCs in breast tissue and the possibility that individual PKCs selectively phosphorylate different proteins and preferentially mediate different biological responses. Further understanding of the role of individual PKCs in mammary cell growth and tumor promotion/progression is likely to lead to new insights for breast cancer diagnosis and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

PKC:

Protein kinase C

DAG:

diacylglycerol

PMA:

phorbol myristic acetate

PLC:

phospholipase

PC-PLC:

phosphatidylcholine-specific phospholipase C

References

  1. Y. Nishizuka (1995). Protein kinases 5: Protein kinase C and lipid signaling for sustained cellular responses.FASEB J. 9:484–496.

    PubMed  Google Scholar 

  2. S. Stabel (1994). Protein kinase C—an enzyme and its relatives.Sem. Cancer Biol. 5:277–284.

    Google Scholar 

  3. S. G. Rhee and K. D. Choi (1992). Regulation of inositol phospholipid-specific phospholipase-C isozymes.J. Biol. Chem. 267:12393–12396.

    PubMed  Google Scholar 

  4. A. Kishimoto, K. Mikawa, K. Hashimoto, I. Yasuda, S. Tanaka, M. Tominaga, T. Kuroda, and Y. Nishizuka (1989). Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain).J. Biol. Chem. 264:4088–4092.

    PubMed  Google Scholar 

  5. D. Lindner, M. Gschwendt, and F. Marks (1992). Phorbol ester-induced down-regulation of the 80-kDa myristoylated alanine-rich C-kinase substrate-related protein in Swiss 3T3 fibroblasts—inhibition by staurosporine.J. Biol. Chem. 267:24–26.

    PubMed  Google Scholar 

  6. N. T. Goode, M. A. N. Hajibagheri, and P. J. Parker (1995). Protein kinase C (PKC)-induced PKC down-regulation. Association with up-regulation of vesicle traffic.J. Biol. Chem. 270:2669–2673.

    PubMed  Google Scholar 

  7. M. G. Kazanietz, L. B. Areces, A. Bahador, H. Mischak, J. Goodnight, J. F. Mushinski, and P. M. Blumberg (1993). Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase-C isozymes.Mol. Pharmacol. 44:298–307.

    PubMed  Google Scholar 

  8. S. L. Hyatt, T. Klauck, and S. Jaken (1990). Protein kinase C is localized in focal contacts of normal but not transformed fibroblasts.Mol. Carcinogen. 3:45–53.

    Google Scholar 

  9. L. Liao, K. Ramsay, and S. Jaken (1994). Protein kinase C isozymes in progressively transformed rat embryo fibroblasts.Cell Growth Diff. 5:1185–1194.

    PubMed  Google Scholar 

  10. S. C. Kiley and P. J. Parker (1995). Differential localization of protein kinase C isozymes in U937 cells: evidence for distinct isozyme functions during monocyte differentiation.J. Cell Sci. 108: 1003–1016.

    PubMed  Google Scholar 

  11. J. Goodnight, H. Mischak, W. Kolch, and J. F. Mushinski (1995). Immunocytochemical localization of eight protein kinase C isozymes overexpressed in NIH 3T3 fibroblasts. Isoform-specific association with microfilaments, Golgi, endoplasmic reticulum, and nuclear and cell membranes.J. Biol. Chem. 270:9991–10001.

    PubMed  Google Scholar 

  12. H. Mischak, J. Goodnight, W. Kolch, G. Martiny-Baron, C. Schaechtle, M. G. Kazanietz, P. M. Blumberg, J. H. Pierce, and J. F. Mushinsk (1993). Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity.J. Biol. Chem. 268:6090–6096.

    PubMed  Google Scholar 

  13. G. James and E. Olson (1992). Deletion of the regulatory domain of protein kinase-C α exposes regions in the hinge and catalytic domains that mediate nuclear targeting.J. Cell Biol. 116:863–874.

    PubMed  Google Scholar 

  14. C. Lehel, Z. Oláh, G. Jakab, Z. Szállási, G. Petrovics, G. Harta, P. M. Blumberg, and W. B. Anderson (1995). Protein kinase C ε subcellular localization domains and proteolytic degradation sites. A model for protein kinase C conformational changes.J. Biol. Chem. 270:19651–19658.

    PubMed  Google Scholar 

  15. S. L. Hyatt, L. Liao, C. Chapline, and S. Jaken (1994). Identification and characterization of α-protein kinase C binding proteins in normal and transformed REF52 cells.Biochemistry 33:1223–1228.

    PubMed  Google Scholar 

  16. L. Liao, S. L. Hyatt, C. Chapline, and S. Jaken (1994). Protein kinase C domains involved in interactions with other proteins.Biochemistry 33:1229–1233.

    PubMed  Google Scholar 

  17. S. Jaken, K. Leach, and T. Klauck (1989). Association of type 3 protein kinase C with focal contacts in rat embryo fibroblasts.J. Cell Biol. 109:697–704.

    PubMed  Google Scholar 

  18. C. Chapline, K. Ramsay, T. Klauck, and S. Jaken (1993). Interaction cloning of protein kinase C substrates.J. Biol. Chem. 268:6858–6861.

    PubMed  Google Scholar 

  19. S. L. Hyatt, L. Liao, A. Aderem, A. Nairn, and S. Jaken (1994). Correlation between protein kinase C binding proteins and substrates in REF52 cells.Cell Growth Diff. 5:495–502.

    PubMed  Google Scholar 

  20. D. Ron, C. Chen, J. Caldwell, L. Jamieson, E. Orr, and D. Mochly-Rosen (1994). Cloning of an intracellular receptor for protein kinase C: A homolog of the β subunit of G proteins.PNAS 91:839–843.

    PubMed  Google Scholar 

  21. J. Staudinger, J. Zhou, R. Burgess, S. J. Elledge, and E. N. Olson (1995). PICK1: A perinuclear binding protein and substrate for protein kinase C isolated by the yeast two-hybrid system.J. Cell Biol. 128:263–271.

    PubMed  Google Scholar 

  22. U. T. Ruegg and G. M. Burgess (1989). Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases.Trends Pharmacol. Sci. 10:218–220.

    PubMed  Google Scholar 

  23. M. G. Kazanietz, X. R. Bustelo, M. Barbacid, W. Kolch, H. Mischak, G. Wong, G. R. Pettit, J. D. Bruns, and P. M. Blumberg (1994). Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C ξ and thevav and c-raf proto-oncogene products.J. Biol. Chem. 269:11590–11594.

    PubMed  Google Scholar 

  24. S. Ahmad and R. I. Glazer (1993). Expression of the antisense cDNA for protein kinase-c-α attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells.Mol. Pharmacol. 43:858–862.

    PubMed  Google Scholar 

  25. N. M. Dean and R. McKay (1994). Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.Proc. Natl. Acad. Sci. U.S.A. 91:11762–11766.

    PubMed  Google Scholar 

  26. W. Li, J.-C. Yu, D.-Y. Shin, and J. H. Pierce (1995). Characterization of a protein kinase C-δ (PKC-δ) ATP binding mutant. An inactive enzyme that competitively inhibits wild type PKC-δ enzymatic activity.J. Biol. Chem. 270:8311–8318.

    PubMed  Google Scholar 

  27. M. T. Diaz-Meco, E. Berra, M. M. Municio, L. Sanz, J. Lozano, I. Dominguez, V. Diazgolpe, M. T. L. Delera, J. Alcami, C. V. Paya, F. Arenzanaseisdedos, J. L. Virelizier, and J. Moscat (1993). A dominant negative protein kinase-C ξ-subspecies blocks NF-κ-B activation.Mol. Cell Bio. 13:4770–4775.

    Google Scholar 

  28. M. T. Diaz-Meco, J. Lozano, M. M. Municio, E. Berra, S. Frutos, L. Sanz, and J. Moscat (1994). Evidence for thein vitro andin vivo interaction ofras with protein kinase C zeta.J. Biol. Chem. 269:31706–31710.

    PubMed  Google Scholar 

  29. S. M. Kahn, K. R. O'Driscoll, W. Jiang, C. Borner, D. B. Xu, M. A. Blackwood, Y. Zhang, K. Nomoto, and I. B. Weinstein (1994). Suppression of mitogenic activity by stable expression of the regulatory domain of PKCβ.Carcinogenesis 15:2919–2915.

    PubMed  Google Scholar 

  30. F. S. Kittrell, C. J. Oborn, and D. Medina (1992) Development of mammary preneoplasiasin vitro from mouse mammary epithelial cell linesin vitro.Cancer Res. 52:1926–1932.

    Google Scholar 

  31. D. Medina, F. S. Kittrell, C. J. Oborn, and M. Schwartz (1993). Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.Cancer Res. 53:668–674.

    PubMed  Google Scholar 

  32. D. Medina, F. S. Kittrell, Y. J. Liu, and M. Schwartz (1993). Morphological and functional properties of TM preneoplastic mammary outgrowths.Cancer Res. 53:663–667.

    PubMed  Google Scholar 

  33. D. R. Welch, A. Neri, and G. L. Nicolson (1983). Comparison of ‘Spontaneous’ and ‘Experimental’ metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones.Invasion Metastasis 3:65–80.

    PubMed  Google Scholar 

  34. Y. Toh, S. D. Pencil, and G. L. Nicolson (1994). A novel candidate metastasis-associated gene,mtal, differentially expressed in highly metastatic mammary adenocarcinoma cell lines.J. Biol. Chem. 269:22958–22963.

    PubMed  Google Scholar 

  35. C. Chapline, B. Mousseau, K. Ramsay, S. Duddy, Y. Li, S. Kiley, and S. Jaken (1995). Identification of a major protein kinase C binding protein and substrate in rat embryo fibroblasts: decreased expression in transformed cells.J. Biol. Chem. (submitted).

  36. Y. Taketani and T. Oka (1983). Tumor promoter 12-O-tetrade-canoylphorbol 13-acetate stimulates proliferation and ductal morphogenesis and inhibits functional differentiation of normal rat mammary epithelial cells in primary culture.Proc. Natl. Acad. Sci. U.S.A. 80:1646–1649.

    PubMed  Google Scholar 

  37. A. Starzec, E. Spanakis, A. Nehme, V. Salle, N. Veber, C. Mainguene, P. Planchon, A. Valette, G. Prevost, and L. Israel (1994). Proliferative effects of epithelial cells to 8-bromo-cyclic AMP and to a phorbol ester change during breast pathogenesis.J. Cell Physiol. 161:31–38.

    PubMed  Google Scholar 

  38. T. Wada, K. M. Darcy, X. Guan, and M. M. Ip (1994). Phorbol 12-myristate 13-acetate stimulates proliferation and ductal morphogenesis and inhibits functional differentiation of normal rat mammary epithelial cells in primary culture.J. Cell Physiol. 158:97–109.

    PubMed  Google Scholar 

  39. R. G. Mehta and R. C. Moon (1986). Effects of 12-O-tetradecanoylphorbol-13-acetate on carcinogen induced mouse mammary lesions in organ culture.Cancer Res. 46:5832–5835.

    PubMed  Google Scholar 

  40. D. Fabbro, W. Kung, S. D. Costa, C. Borner, U. Regenass, and U. Eppenberger (1991). Involvement of protein kinase C in the growth regulation of human breast cancer cells. In R. B. Dickson and M. E. Lippman (eds.),Genes, Oncogenes, and Hormones, Kluwer Academic, Boston, pp. 229–248.

    Google Scholar 

  41. A. Valette, N. Gas, S. Jozan, F. Roubinet, M. Dupont, and F. Bayard (1987). Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events.Cancer Res. 47:1615–1620.

    PubMed  Google Scholar 

  42. M. Koga, E. Musgrove, and R. Sutherland (1990). Differential effects of phorbol esters on epidermal growth factor receptors in estrogen receptor postive and negative breast cancer cell lines.Cancer Res. 50:4849–4855.

    PubMed  Google Scholar 

  43. C. Borner, I. Filipuzzi, M. Wartmann, U. Eppenberger, and D. Fabbro (1989). Biosynthesis and posttranslational modifications of protein kinase C in human breast cancer cells.J. Biol. Chem. 264: 13902–13909.

    PubMed  Google Scholar 

  44. M. J. Kennedy, L. J. Prestigiacomo, G. Tyler, W. S. May, and N. E. Davidson (1992). Differential effects of bryostatin-1 and phorbol ester on human breast cancer cell lines.Cancer Res. 52:1278–1283.

    PubMed  Google Scholar 

  45. N. Guilbaud, M. F. Pichon, J. C. Faye, F. Bayard, and F. Valette (1988). Modulation of estrogen receptors by phorbol diesters in human breast MCF-7 cell line.Mol. Cell. Endocrinol. 56:157–163.

    PubMed  Google Scholar 

  46. M. Tzukerman, X. Zhang, and M. Pfahl (1991). Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate: a molecular analysis.Mol. Endocrinol. 5:1983–1992.

    PubMed  Google Scholar 

  47. S. Arnold, J. Obourn, H. Jaffe, and A. C. Notides (1994). Serine 167 is the major estradiol induced phosphorylation site on the human estrogen receptor.Mol. Endocrinol. 8: 1208–1214.

    PubMed  Google Scholar 

  48. H. Cho and B. S. Katzenellenbogen (1993). Synergistic activation of estrogen receptor mediated transcription by estradiol and protein kinase activities.Mol. Endocrinol. 7:441–452.

    PubMed  Google Scholar 

  49. G. Fuh and J. A. Wells (1995). Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines.J. Biol. Chem. 270:13133–13137.

    PubMed  Google Scholar 

  50. R. Banerjee and B. K. Vonderhaar (1992). Prolactin-induced protein kinase-C activity in a mouse mammary cell line (NOG-8).Mol. Cell. Endocrinol. 90:61–67.

    PubMed  Google Scholar 

  51. B. M. Marte, T. Meyer, S. Stabel, J. R. Standke, S. Jaken, D. Fabbro, and N. E. Hynes (1994). Protein kinase C and mammary cell differentiation: involvement of protein kinase C α in the induction of β-casein expression.Cell Growth Diff. 5:1–10.

    PubMed  Google Scholar 

  52. J. Rillema and S. B. Waters (1986). Phorbol myristate acetate stimulates RNA and casein synthesis in cultured mouse mammary gland tissues.Proc. Soc. Exp. Biol. Med. 182:11–14.

    PubMed  Google Scholar 

  53. C. J. Ormandy, C. S. L. Lee, P. A. Kelly, and R. L. Sutherland (1993). Regulation of prolactin receptor expression by the tumor promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human breast cancer cells.J. Cell. Biochem. 52:47–56.

    PubMed  Google Scholar 

  54. N. J. Kenney and R. B. Dickon (1996). Growth factor and sex steroid interactions in breast cancer.J. Mam. Gland Biol. Neoplasia. 1(2):189–198.

    Google Scholar 

  55. N. Hynes (1996). Erb2 activation and signal transduction in normal and malignant mammary cells.J. Mam. Gland Biol. Neoplasia 1(2):199–206.

    Google Scholar 

  56. T. Hunter, N. Ling, and J. A. Cooper (1984). Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane.Nature 311:480–483.

    PubMed  Google Scholar 

  57. T. Hudson, J. Santon, and G. Gill (1995). Regulation of epidermal growth factor receptor gene expression.Mol. Endocrinol. 3:400–408.

    Google Scholar 

  58. N. Kyprianou, H. F. English, N. E. Davidson, and J. T. Isaacs (1991). Programmed cell death during regression of MCF-7 human breast cancer following estrogen ablation.Cancer Res. 51:162–166.

    PubMed  Google Scholar 

  59. A. M. Warri, R. L. Huovinen, A. M. Laine, P. M. Martikainen, and P. L. Harkonen (1993). Apoptosis in toremifene-induced growth inhibition of human breast cancer cellsin vivo andin vitro.JNCI 85:1412–1418.

    PubMed  Google Scholar 

  60. D. J. McConkey, P. Hartzell, M. Jondal, and S. Orrenius (1989). Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C.J. Biol. Chem. 264:13399–13402.

    PubMed  Google Scholar 

  61. A. Geier, C. Weiss, R. Beery, M. Haimsohm, R. Hemi, Z. Malik, and A. Karasik (1995). Multiple pathways are involved in protection of MCF-7 cells against death due to protein synthesis inhibition.J. Cell Physiol. 163:570–576.

    PubMed  Google Scholar 

  62. M. Bignon, J. Ogita, A. Kishimoto, and Y. Nishizuka (1990). Protein kinase C subspecies in estrogen receptor positive and negative human bresat cancer cell lines.Biochem. Biophys. Res. Commun. 171:1071–1078.

    PubMed  Google Scholar 

  63. M. Simboli-Cambell and J. E. Welsh (1995). 1,25 Dihydroxyvitamin D3: coordinate regulator of active cell death and proliferation in MCF-7 breast cancer cells. In M. Tenniswood and H. Michna (eds.),Workshop on Apoptosis in Hormone Dependent Cancers, Springer Verlag, Berlin, pp. 181–200.

    Google Scholar 

  64. K. Kiguchi, D. Glesne, C. Chubb, H. Fujiki, and E. Huberman (1994). Differential induction of apoptosis in human breast cancer cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A.Cell Growth Diff. 5:995–1004.

    PubMed  Google Scholar 

  65. J. Halstead, K. Kemp, and R. A. Ignotz (1995). Evidence for involvement of phosphatidycholine-phospholipase C and protein kinase C in transforming growth factor β signaling.J. Biol. Chem. 270:13600–13603.

    PubMed  Google Scholar 

  66. M. Guerrin, H. Prats, P. Mazars, and A. Valette (1992). Antipro-liferative effect of phorbol esters on MCF-7 human breast adenocarcinoma cells: relationship with enhanced expression of transforming growth-factor β1.Biochem. Biophys. Acta 1137:116–120.

    PubMed  Google Scholar 

  67. S. J. Kim, F. Denhez, K. Y. Kim, J. T. Holt, M. B. Sporn, and A. B. Roberts (1989). Activation of the second promoter of the transforming growth-factor β1 gene by transforming growth factor β1 and phorbol ester occurs through the same target sequences.J. Biol. Chem. 264:19373–19378.

    PubMed  Google Scholar 

  68. G. Buellomo, M. Perotti, F. Taddei, F. Mirabelli, G. Finardi, P. Nicotera, S. Orrenius (1992). Tumor necrosis factor α induces apoptosis in mammary adenocarcinoma cells by an increase in intranuclear free calcuim concentration and DNA fragmentation.Cancer Res. 52:1342–1346.

    PubMed  Google Scholar 

  69. R. A. Heller and M. Kronke (1994). Tumor necrosis factor receptor mediated signaling pathways.J. Cell Biol. 126:5–9.

    PubMed  Google Scholar 

  70. L. Obeid and Y. A. Hannun (1995). Ceramide: a stress signal and mediator of growth suppression and apoptosis.J. Cell. Biochem. 58:191–198.

    PubMed  Google Scholar 

  71. D. Jeoung, B. Tang, and M. Sonenberg (1995). Effects of tumor necrosis factor a on anti-mitogenicity and cell cycle related proteins in MCF-7.J. Biol. Chem. 270:18367–18373.

    PubMed  Google Scholar 

  72. J. Lozano, E. Berra, M. M. Municio, M. T. Diaz-Meco, I. Dominguez, L. Sanz, and J. Moscat (1994). Protein kinase C ζ isoform is critical for kB-dependent promoter activation by sphinogmyelinase.J. Biol. Chem. 269:19200–19202.

    PubMed  Google Scholar 

  73. H. Parenteau, T. F. Ho, L. A. Eckel, and K. K. Carroll (1992). Effects of a long-chain fatty amine on mammary carcinogenesis induced in female Sprague-Dawley rats by DMBA.Nutr. Cancer 17:235–241.

    PubMed  Google Scholar 

  74. P. W. Sylvester, H. P. Birkenfeld, H. L. Hosick, and K. P. Briski (1994). Fatty acid modulation of epidermal growth factor-induced mouse mammary epithelial cell proliferationin vitro.Exp. Cell Res. 214:145–153.

    PubMed  Google Scholar 

  75. T. Kano-Sueoka and M. E. Nicks (1993). Abnormal function of protein kinase C in cells having phosphatidylethanolamine-deficient and phosphatidylcholine-excess membranes.Cell Growth Diff. 4:533–537.

    PubMed  Google Scholar 

  76. G. Yu, S. Ahmad, A. Aquino, C. R. Fairchild, J. B. Trepel, S. Ohno, K. Suzuki, T. Tsuruo, K. H. Cowan, and R. I. Glazer (1991). Transfection with protein kinase C-α confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein.Cancer Commun. 3:181–189.

    PubMed  Google Scholar 

  77. A. Ahmed and R. I. Glazer (1993). Expression of the antisense cDNA for protein kinase C α attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells.Mol. Pharmacol. 43:858–862.

    PubMed  Google Scholar 

  78. S. P. Hardy, H. R. Goodfellow, M. A. Valverde, D. R. Gill, F. V. Sepúlveda, and C. F. Higgins (1995). Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels.EMBO J. 14:68–75.

    PubMed  Google Scholar 

  79. S. Ahmad, A. R. Safa, and R. I. Glazer (1994). Modulation of P-glycoprotein by protein kinase C a in a baculovirus expression system.Biochemistry 33:10313–10318.

    PubMed  Google Scholar 

  80. C. Faucher, J. Capdevielle, I. Canal, P. Ferrara, H. Mazarguil, W. L. Mcguire, and J. M. Darbon (1993). The 28-kda protein whose phosphorylation is induced by protein kinase C activators in MCF-7 cells belongs to the family of low molecular mass heat shock proteins and is the estrogen-regulated 24-kda protein.J. Biol. Chem. 268:15168–15173.

    PubMed  Google Scholar 

  81. S. Osterreich, C. M. Weng, M. Qiu, S. G. Hisenbeck, C. K. Osborne, and S. Fuqua (1993). The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cells.Cancer Res. 53:4443–4448.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susan Jaken.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiley, S.C., Welsh, J., Narvaez, C.J. et al. Protein kinase C isozymes and substrates in mammary carcinogenesis. J Mammary Gland Biol Neoplasia 1, 177–187 (1996). https://doi.org/10.1007/BF02013641

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02013641

Key words

Navigation